Latest Articles

  • A less common source of dyspnea in scleroderma
    Faysal Altahawi and M. Chadi Alraies, MD, FACP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 801-802; DOI: https://doi.org/10.3949/ccjm.78a.11014

    A 48-year-old man with scleroderma reports progressive shortness of breath, fatigue, and melena over the past month. What is the link?

  • History and current concepts in the pathogenesis of PML
    Eugene O. Major, PhD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S3-S7; DOI: https://doi.org/10.3949/ccjm.78.s2.02
  • In reply: Atrial fibrillation management: Issues of concern (April 2011)
    Thomas Callahan, MD and Brian Baranowski, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 720-721; DOI: https://doi.org/10.3949/ccjm.78c.1102
  • PML and rheumatology: The contribution of disease and drugs
    Eamonn S. Molloy, MD, MS, MRCPI
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S28-S32; DOI: https://doi.org/10.3949/ccjm.78.s2.07
  • The bittersweet of steroid therapy
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 709; DOI: https://doi.org/10.3949/ccjm.78b.11011

    Every physician has had patients with the long-term effects of glucocorticoid therapy, including diabetes.

  • Introduction
    Leonard Calabrese, DO
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S2; DOI: https://doi.org/10.3949/ccjm.78.s2.01
  • Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them
    M. Cecilia Lansang, MD, MPH and Leighanne Kramer Hustak, DNP, BC-FNP, CDE
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 748-756; DOI: https://doi.org/10.3949/ccjm.78a.10180

    Choosing specific drugs to counter hyperglycemia, tests for adrenal suppression and systemic glucocorticoid absorption, and how and why to taper these drugs.

  • The clinical features of PML
    Joseph R. Berger, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S8-S12; DOI: https://doi.org/10.3949/ccjm.78.s2.03
  • In reply: Angioedema due to the renin inhibitor aliskiren (May 2011)
    Aleksandr Korniyenko, MD and Franz H. Messerli, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 722-723; DOI: https://doi.org/10.3949/ccjm.78c.1104
  • Pharmacovigilance and PML in the oncology setting
    Charles L. Bennett, MD, PhD, MPP
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S13-S17; DOI: https://doi.org/10.3949/ccjm.78.s2.04

Pages